TREMONT STRATEGIES GROUP LLC for AMAG PHARMACEUTICAL
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2021 | $40,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 22, 2021 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical issues; access to women's health pharmaceutical products.
Foreign entity interest: COVIS Pharma GmbH, identified on Line 27, holds the intellectual property underlying AMAG Pharmaceuticals' work and would benefit from AMAG's success in ensuring public access to its product.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID J GARRIEPY | — |
| LIESL GREBENSTEIN SHEEHAN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COVIS TOPCO S.A.R.L | Luxembourg | Luxembourg | 100.0% | — |
| COVIS HOLDCO S.A.R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS FINCO S.A.R.L | Luxembourg | Luxembourg | 100.0% | — |
| COVIS GROUP S.A.R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS PHARMA GMBH | Switzerland | Switzerland | — | — |
| APOLLO OVERSEAS PARTNERS (892 AIV) IX, L.P. | Cayman Islands | Cayman Islands | 23.5% | — |
| AP IX (EURO AIV) L.P. | Cayman Islands | Cayman Islands | 42.1% | — |
| COVIS MIDCO 1 S.A.R.L. | Luxembourg | Luxembourg | 100.0% | — |
| COVIS EQUITYCO SCA | Luxembourg | Luxembourg | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.